BiophysicsbioRxivPreprint
T2 heterogeneity provides a sensitive measure of early tumor response to radiotherapy
M. R. Tomaszewski, W. Dominguez Viqueira, A. Ortiz…·R. J. Gillies
This paper introduces a T2 MRI-based biomarker to assess early tumor response to radiotherapy in pancreatic cancer models, showing high sensitivity and robustness.